


Professor Orenstein directs the ultra-modern Maurice and Gabriela Goldschleger Center for Advanced Medical Technologies at Sheba Medical Center. The Center brings clinicians, scientists, academics and the medical technology industry together under one roof to foster a unified working environment for the development of diagnostic and therapeutic technologies. Chairman of the Plastic Surgery Department at Sheba hospital Prof. Orenstein is an internationally recognized expert on the applications of lasers in medicine. For 12 years, Prof. Orenstein served as Co-Chairman of the Israel Medical Association and was the Israeli representative on the board of the World Medical Association for 15 years. Orenstein is a member of numerous professional organizations dealing with the technical and ethical challenges of medicine.

DAGESH GROUP was founded in 1993 by the Owner and Chairman Mr. Kobi Franken, a world-class authority in the field of metal cutting applications and opto-mechanical systems. The Group’s business spans the complete range of design, production, procurement, assembly, integration, calibration and delivery of optical turn-key systems serving world-leading manufacturers of semiconductor, medical & laser aesthetic, printing and aviation products.

Richel is Founder and CEO of Rimonci Capital, the member of the fund investment committee. She is responsible for Rimonci overall strategies and transactions control. Prior to founding Rimonci at start of 2016, Richel served as CEO of a comprehensive IT group in China with 1.5 billion USD in sales, and also Executive Director of HK listed company and chairman of Shanghai listed company in this group. During her tenure, Richel was responsible for different business investment and operation, especially electronics, IC substrate, enterprise software, system integration and finally the overall management of the whole group. With more than 17 years of investment, mergers and acquisitions, business operation and management experience, she has distinguished tracking record on setting up new business and grow business from earlier stage to mature stage either by organic growth or through investment. Richel also have abundant cross-board working experience, competent for multiple board governance structure and management. Richel earned MS degree in economics and BS degree in engineering. She also Received Senior Leadership Training Certification from Yale School of Management. Acquired the certification of Eye, Ear, Nose & Throat Innovation by Biodesign of Stanford and Bayer’s Eye Institute. With the qualifications for securities and funds in China. Be the member of Singapore National Eye Center Ophthalmic Technologies Incubator Venture Capital advisory panel.

Mr. Zhang is director from Infinity Equity and focuses on healthcare investment for more than 10 years. Mr. Zhang worked at China Resources Group and China Merchants Group, two largest conglomerates in China. With many years of experience concerning IPO, PIPE investment, debt and equity financing, Mr. Zhang has invested double-digit medical firms and executed several M&A cases across healthcare industry. Mr. Zhang graduated from Johns Hopkins University Carey Business School with graduate degree and from Central University of Finance and Economy with bachelor’s degree. Mr. Zhang is CFA and sponsor representative in HK.

Tsuyoshi (Josh) Chiwata, MS, is a Director within in Santen Venture Management at Santen Pharmaceutical Co. Ltd., one of the world’s leading specialist ophthalmic pharmaceutical companies, founded over a century ago. Mr. Chiwata has a Master’s degree in Chemistry from Kyushu University, and has spent more than a decade in business development in pharmaceutical and life-science industries. In addition, Mr. Chiwata spent seven years with the Japanese firm, JAFCO Co. Ltd, where he engaged in a variety of opportunities for evaluation and investment in biotechnology and pharmaceuticals.
This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information